68 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... and CKD EMPA-REG ... Empagliflozin lowered CV ... SGLT2i in HF and CKD ... visualabstract #table #CVD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
major adverse CV ... major adverse CV ... Improved outcomes in CKD ... medications #table #comparison
Gout Management in CKD
 • Colchicine
 • NSAID
 • Glucocorticoid
 • ACTH
 • Interleukin-1 Inhibitors

#Gout #Management
Management in CKD ... Gout #Management #CKD ... rheumatology #treatment #comparison
Diagnostic algorithm for a child or adolescent with suspected pulmonary hypertension. CHD, congenital heart disease; CPET,
CHD, congenital ... hereditary pulmonary arterial ... idiopathic pulmonary arterial ... bronchopulmonary dysplasia; CLD
Causes of Polyneuropathy - Differential Diagnosis Algorithm
 • Metabolic: DM, Hypothyroidism, CKD, Cirrhosis, Nutritional deficiency
 •
Hypothyroidism, CKD ... Paraneoplastic, CTD ... Mitochondrial issues - VA
Reduced DOAC Dosing for Atrial Fibrillation 

#DOAC #Reduced #Dosing #Reduction #Dose #Anticoagulation #Pharmacology #AFib #Renal #CKD
DOAC Dosing for Atrial ... #AFib #Renal #CKD
Stroke Blood Vessel Localization and corresponding territories on MRI

by Jeremy Heit, MD, PhD @JeremyHeitMDPHD

#Stroke #CVA #Localization
JeremyHeitMDPHD #Stroke #CVA ... MRI #Radiology #Arteries
Pharmacokinetics of commonly used diuretics medications in CKD, Cirrhotic Ascites, and Heart Failure
 • Furosemide
 •
medications in CKD ... Pharmacokinetics #halflife #comparison
Algorithmic Approach to Hypothyroidism - Differential Diagnosis and Management Framework

Central Hypothyroidism (Secondary or tertiary) ↓TSH, ↓FT4
≤ 65 yo; no CVD ... > 65 yo or CVD
A primer on the causes, evaluation and management of Acute Myocardial Infarction in Young Patients. 
Obstructive:
• Atheromatous CAD ... non-obstructive coronary arteries ... Non-atheromatous CAD